Colgate Palmolive India reported a decline in first-quarter profit on Tuesday, as feeble urban demand and intensified ...

Colgate-Palmolive Company (NYSE:CL) is one of the most profitable consumer stocks to buy now. UBS lowered its price target on ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $100.6, along with a high estimate of $108.00 and a low estimate of $87.00. This upward ...

Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

An immediate pick-up in growth appears tough for Colgate amid stiff competition and sustained tepid urban demand. A high base ...

Palmolive's weak performance to continue in the near-term, with the mentioned challenges to persist in the second quarter as ...

Colgate Palmolive share price hit a 52-week low today on the back of weak Q1 results, weighed down by poor demand trends in urban market. Analysts decode the stock strategy going forward ...

Results: Total expenses stood at ₹1,020.05 crore, marginally lower than ₹1,030.86 crore a year ago but up from ₹1,003.95 ...

Palmolive Company announced today that Colgate Women’s Games, the nation’s longest-running indoor Track & Field series for ...

Colgate-Palmolive highlighted that the June quarter results reflect the persistent headwinds from tough operating conditions, ...

The National Institute for the Protection of Consumer Rights (Pro Consumidor) and the General Directorate of Medicines, Food, ...

Post Q1 results, brokerages took a cautious stance on Colgate Palmolive India Ltd. While JP Morgan maintained 'overweight' ...